title: [Effect of drugs of various groups on the course of experimental local pyo-inflammatory processes].
abstract: To develop new approaches to providing higher efficacy of antibacterial therapy of purulent infection, experiments on 104 rats were performed. A decrease in the inflammation was shown in a series of the experiments with the dermonecrotic test using mono- and mixed cultures of Staphylococcus aureuo, Pseudomonas aeruginosa and Escherichia coli at the background of the animal treatment with anapriline and heparin. The effect of mezatone and dicinone was the opposite one. The drugs had different effects on the host response to the introduction of microorganisms of various species as mono- and mixed cultures. The experiments on a group of animals with wound infection not subjected to the preliminary alteration of the tissues demonstrated that the treatment with gentamicin and anapriline combinations was more efficient than the gentamicin monotherapy. The use of anapriline improved the antibiotic pharmacokinetics, had a favourable effect on the wound reparation, promoted a decrease in the count of viable microbes in the wound secretion and increased the antibiotic concentration gradient.
authors.forename: D D
authors.initials: DD
authors.lastname: Men'shikov
authors.forename: T A
authors.initials: TA
authors.lastname: Vasina
authors.forename: A V
authors.initials: AV
authors.lastname: Volenko
authors.forename: G V
authors.initials: GV
authors.lastname: Zalogueva
authors.forename: V A
authors.initials: VA
authors.lastname: Vasil'ev
mesh_terms: D018663:Adrenergic Agents / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D004359:Drug Therapy, Combination; D004979:Ethamsylate / Q000627:therapeutic use; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D007249:Inflammation / Q000188:drug therapy* / Q000382:microbiology / Q000517:prevention & control; D008826:Microbial Sensitivity Tests; D010656:Phenylephrine / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D051381:Rats; D017208:Rats, Wistar
chemical_list: D018663:Adrenergic Agents; D000319:Adrenergic beta-Antagonists; D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D005839:Gentamicins; D010656:Phenylephrine; D004979:Ethamsylate; D006493:Heparin; D011433:Propranolol
vernacular_title: Vliianie lekarstvennykh preparatov razlichnykh grupp na techenie éksperimental'nykh mestnykh gnoĭno-vospalitel'nykh protsessov.